Anti-UBAC2 monoclonal antibody

Pre-made anti-UBAC2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to UBAC2/UBAC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2219-Ab-1/ GM-Tg-hg-IP2219-Ab-2Anti-Human UBAC2 monoclonal antibodyHuman
GM-Tg-rg-IP2219-Ab-1/ GM-Tg-rg-IP2219-Ab-2Anti-Rat UBAC2 monoclonal antibodyRat
GM-Tg-mg-IP2219-Ab-1/ GM-Tg-mg-IP2219-Ab-2Anti-Mouse UBAC2 monoclonal antibodyMouse
GM-Tg-cynog-IP2219-Ab-1/ GM-Tg-cynog-IP2219-Ab-2Anti-Cynomolgus/ Rhesus macaque UBAC2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2219-Ab-1/ GM-Tg-felg-IP2219-Ab-2Anti-Feline UBAC2 monoclonal antibodyFeline
GM-Tg-cang-IP2219-Ab-1/ GM-Tg-cang-IP2219-Ab-2Anti-Canine UBAC2 monoclonal antibodyCanine
GM-Tg-bovg-IP2219-Ab-1/ GM-Tg-bovg-IP2219-Ab-2Anti-Bovine UBAC2 monoclonal antibodyBovine
GM-Tg-equg-IP2219-Ab-1/ GM-Tg-equg-IP2219-Ab-2Anti-Equine UBAC2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2219-Ab-1/ GM-Tg-hg-IP2219-Ab-2; GM-Tg-rg-IP2219-Ab-1/ GM-Tg-rg-IP2219-Ab-2;
GM-Tg-mg-IP2219-Ab-1/ GM-Tg-mg-IP2219-Ab-2; GM-Tg-cynog-IP2219-Ab-1/ GM-Tg-cynog-IP2219-Ab-2;
GM-Tg-felg-IP2219-Ab-1/ GM-Tg-felg-IP2219-Ab-2; GM-Tg-cang-IP2219-Ab-1/ GM-Tg-cang-IP2219-Ab-2;
GM-Tg-bovg-IP2219-Ab-1/ GM-Tg-bovg-IP2219-Ab-2; GM-Tg-equg-IP2219-Ab-1/ GM-Tg-equg-IP2219-Ab-2
Products NameAnti-UBAC2 monoclonal antibody
Formatmab
Target NameUBAC2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-UBAC2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2219-Ag-1Recombinant multi-species UBAC2/ PHGDHL1 protein
    ORF Viral VectorpGMAP000462Human UBAC2 Adenovirus plasmid
    ORF Viral VectorvGMAP000462Human UBAC2 Adenovirus particle
    ORF Viral VectorpGMLPm001864mouse Ubac2 Lentivirus plasmid
    ORF Viral VectorvGMLPm001864mouse Ubac2 Lentivirus particle


    Target information

    Target IDGM-IP2219
    Target NameUBAC2
    Gene ID337867,68889,361094,703484,608309,101080352,100125312,100061123
    Gene Symbol and Synonyms1190008A14Rik,PHGDHL1,UBAC2
    Uniprot AccessionQ8NBM4
    Uniprot Entry NameUBAC2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000134882
    Target ClassificationN/A

    The target: UBAC2, gene name: UBAC2, also named as PHGDHL1. Involved in negative regulation of canonical Wnt signaling pathway and negative regulation of retrograde protein transport, ER to cytosol. Acts upstream of or within protein localization to endoplasmic reticulum. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.